Cargando…

CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression

The underlying molecular mechanisms of tumorigenesis and progression of non-small cell lung cancer (NSCLC) are not yet fully elucidated. In the present study, in vitro functional dissections suggest that siRNA-mediated silencing of CCNE2 profoundly attenuated the proliferative and colony-formative a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Deqin, He, Jing, Zhang, Wei, Wang, Kai, Jin, Shidai, Li, Jun, Gao, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346078/
https://www.ncbi.nlm.nih.gov/pubmed/32487779
http://dx.doi.org/10.18632/aging.103280
_version_ 1783556328922284032
author Wu, Deqin
He, Jing
Zhang, Wei
Wang, Kai
Jin, Shidai
Li, Jun
Gao, Wen
author_facet Wu, Deqin
He, Jing
Zhang, Wei
Wang, Kai
Jin, Shidai
Li, Jun
Gao, Wen
author_sort Wu, Deqin
collection PubMed
description The underlying molecular mechanisms of tumorigenesis and progression of non-small cell lung cancer (NSCLC) are not yet fully elucidated. In the present study, in vitro functional dissections suggest that siRNA-mediated silencing of CCNE2 profoundly attenuated the proliferative and colony-formative abilities of NSCLC PC9 and HCC827 cells, while forced overexpression of CCNE2 significantly strengthened the proliferative and colony-formative capabilities of these cells. Intriguingly, by ChIP and luciferase reporter gene assays, we observed that CARM1 is recruited to the promoter regions of CCNE2 gene and acts as a transcriptional activator. Mechanically, the asymmetric di-methylation of H3R17me2a and H3R26me2a, as the catalytic substrates of CARM1, were highly enriched at the core promoter regions of CCNE2 gene, thereby activating the expression of CCNE2. In vitro and in vivo rescue experiments demonstrated that restoration of CCNE2 expression significantly abolished the CARM1 shRNA-mediated inhibition of cell proliferation, indicating that the oncogenic function of CARM1, at least partially, depended on the activation of CCNE2. Inhibition of CARM1 enzymatic activity could significantly repress CCNE2 expression in NSCLC cells. In addition, the expression of CARM1 was significantly elevated and positively correlated with CCNE2 levels in 20 cases of NSCLC patients. Both CARM1 and CCNE2 are highly associated with shorter 10-year overall survival of at a large cohort of 461 cases of NSCLC patients from the Kaplan-Meier plotter database. To summarize, these findings provide compelling evidence that CARM1 could promote NSCLC progression via activation of CCNE2, paving the way for future therapeutic strategies in NSCLC.
format Online
Article
Text
id pubmed-7346078
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-73460782020-07-15 CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression Wu, Deqin He, Jing Zhang, Wei Wang, Kai Jin, Shidai Li, Jun Gao, Wen Aging (Albany NY) Research Paper The underlying molecular mechanisms of tumorigenesis and progression of non-small cell lung cancer (NSCLC) are not yet fully elucidated. In the present study, in vitro functional dissections suggest that siRNA-mediated silencing of CCNE2 profoundly attenuated the proliferative and colony-formative abilities of NSCLC PC9 and HCC827 cells, while forced overexpression of CCNE2 significantly strengthened the proliferative and colony-formative capabilities of these cells. Intriguingly, by ChIP and luciferase reporter gene assays, we observed that CARM1 is recruited to the promoter regions of CCNE2 gene and acts as a transcriptional activator. Mechanically, the asymmetric di-methylation of H3R17me2a and H3R26me2a, as the catalytic substrates of CARM1, were highly enriched at the core promoter regions of CCNE2 gene, thereby activating the expression of CCNE2. In vitro and in vivo rescue experiments demonstrated that restoration of CCNE2 expression significantly abolished the CARM1 shRNA-mediated inhibition of cell proliferation, indicating that the oncogenic function of CARM1, at least partially, depended on the activation of CCNE2. Inhibition of CARM1 enzymatic activity could significantly repress CCNE2 expression in NSCLC cells. In addition, the expression of CARM1 was significantly elevated and positively correlated with CCNE2 levels in 20 cases of NSCLC patients. Both CARM1 and CCNE2 are highly associated with shorter 10-year overall survival of at a large cohort of 461 cases of NSCLC patients from the Kaplan-Meier plotter database. To summarize, these findings provide compelling evidence that CARM1 could promote NSCLC progression via activation of CCNE2, paving the way for future therapeutic strategies in NSCLC. Impact Journals 2020-06-02 /pmc/articles/PMC7346078/ /pubmed/32487779 http://dx.doi.org/10.18632/aging.103280 Text en Copyright © 2020 Wu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Wu, Deqin
He, Jing
Zhang, Wei
Wang, Kai
Jin, Shidai
Li, Jun
Gao, Wen
CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title_full CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title_fullStr CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title_full_unstemmed CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title_short CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
title_sort carm1 promotes non-small cell lung cancer progression through upregulating ccne2 expression
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346078/
https://www.ncbi.nlm.nih.gov/pubmed/32487779
http://dx.doi.org/10.18632/aging.103280
work_keys_str_mv AT wudeqin carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT hejing carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT zhangwei carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT wangkai carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT jinshidai carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT lijun carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression
AT gaowen carm1promotesnonsmallcelllungcancerprogressionthroughupregulatingccne2expression